CYP46A1 and Alzheimer disease: In the AD models of amyloidogenesis (APP23 and APP/PS mice), neuronal overexpression of CYP46A1 before or after the onset of amyloid plaques decreased the brain Aβ deposits and improved animal performance in the MWM test of the investigated APP23 model.